BRIDGEBIO PHARMA INC - NOTE 2.500% 3/1

Historical Holders from Q1 2021 to Q1 2025

CUSIP: 10806XAB8
Type / Class: Debt / NOTE 2.500% 3/1
All holders as of December 31, 2024: Q4 2024
Principal, excl. options: 563M
Holdings value: $591M
% of all portfolios: 0.001%
Grand Portfolio weight change: 0%
Number of holders: 43
Number of buys: 15
Number of sells: -20
Average Value change %: 0%
Average buys %: +0%
Average sells %: 0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Institutional Holders of BRIDGEBIO PHARMA INC - NOTE 2.500% 3/1

Period	Principal	Value	Change	Price	Investors
2025 Q1	$525K	$567K	-$234K	$1.08	1
2024 Q4	$563M	$591M	-$57.4M	$1.05	43
2024 Q3	$580M	$599M	+$11.9M	$1.03	42
2024 Q2	$560M	$566M	-$1.6M	$1.01	40
2024 Q1	$560M	$603M	-$106M	$1.08	40
2023 Q4	$530M	$642M	+$21.4M	$1.21	42
2023 Q3	$527M	$517M	+$21.5M	$0.96	40
2023 Q2	$509M	$408M	-$33.1M	$0.78	35
2023 Q1	$537M	$417M	+$6.94M	$0.74	36
2022 Q4	$533M	$244M	+$73.2K	$0.45	31
2022 Q3	$392M	$235M	-$522K	$0.59	32
2022 Q2	$404M	$224M	-$83.8M	$0.54	33
2022 Q1	$548M	$330M	-$9.34M	$0.59	35
2021 Q4	$524M	$392M	-$23.3M	$0.73	39
2021 Q3	$533M	$746M	-$33.8M	$1.38	42
2021 Q2	$570M	$939M	+$82.2M	$1.64	38
2021 Q1	$519M	$859M	+$842M	$1.65	35